Effect of Trasina®, an ayurvedic herbal formulation, on experimental models of Alzheimer's disease and central cholinergic markers in rats

Journal of Alternative and Complementary Medicine

Volumn 3, Issue 4, 1997, Pages 327-336

  Bhattacharya, S K ^a   Kumar, A ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b Paul Flechsig Institute for Brain Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; COLCHICINE; IBOTENIC ACID; MUSCARINIC RECEPTOR;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; AYURVEDA; BINDING SITE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; FRONTAL LOBE; HIPPOCAMPUS; MALE; MEDICINAL PLANT; MEMORY DISORDER; METABOLISM; PHYTOTHERAPY; RAT; WISTAR RAT;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; BINDING SITES; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC ANTAGONISTS; COLCHICINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; HIPPOCAMPUS; IBOTENIC ACID; MALE; MEDICINE, AYURVEDIC; MEMORY DISORDERS; PHYTOTHERAPY; PLANTS, MEDICINAL; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC;

EID: 0031297391     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.1997.3.327     Document Type: Article

References (47)

1. Armitage D, Berry G 1987 Statistical Methods in Medical Research. Second edition. Blackwell Scientific Publications, London.
2. Bartus RT, Flicker C, Dean RI, Pontecorvo H, Figueiredo JC, Fisher SK. Selective memory loss following nucleus basilis lesions: Long term behavioural recovery despite persistent cholinergic deficiencies. Pharmacol Biochem Behav 1985;25:125-135.
3. Bhattacharya SK 1993 Evaluation of adaptogenic activity of Trasina, an Ayurvedic herbal formulation. In Mukherjee B (ed) Traditional Medicine. Oxford & IBH Publishing Co., New Delhi, p. 320.
4. Bhattacharya SK. Nootropic effect of BR-16A (Mentat), a psychotropic herbal formulation on cognitive deficits induced by prenatal undernutrition, postnatal environmental impoverishment and hypoxia in rats. Indian J Exp Biol 1994;32:31-36.
5. Bhattacharya SK, Kumar A, Ghosal S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer's disease and perturbed cholinergic markers of cognition in rats. Phytother Res 1995a; 9:110-113.
6. Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 1997a;35:236-239.
7. Bhattacharya SK, Bhattacharya A, Ghosal S. Antioxidant activity of Ocimum sanctum: an experimental study. Indian J Med Biochem 1997b: In press.
8. Bhattacharya SK, Satyan KS, Chakrabarti A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol 1997c:35:297-299.
9. Bhattacharya SK, Sen AP, Ghosal S. Effects of shilajit on biogenic free radicals. Phytother Res 1995b;9:56-59.
10. Bhattacharya SK, Upadhyay SN, Jaiswal AK, Sen AP. Effect of piracetam on electroshock induced amnesia and decreased in brain acetylcholine. Indian J Exp Biol 1993;31:822-824.
11. Bondy SC 1981 Neurotransmitter binding interaction as a screen for neurotoxicity. In Vernadakis A, Prasad KD (eds) Mechanisms of Actions of Neurotoxic Substances. Raven Press, New York, p. 21.
12. Chakrabarti A, Biswas A, Tandon R, Bhattacharya SK. Recent approaches to pharmacological management of senile dementia. J Intern Med 1996;7:18-21.
13. Dawson GR, Heyes CM, Iversen SD. Pharmacological mechanisms and animal models of cognition. Behav Pharmacol 1992;3:285-297.
14. Dekker AJAM, Connor DJ, Thal LJ. The role of cholinergic projections from nucleus basilis in memory. Neurosci Biobehav Res 1991;35:299-317.
15. Emerich DF, Walsh TJ. Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicine. Brain Res 1990;517:157-167.
16. Fibiger HC. Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence. Trend Neurosci 1991;14:220-223.
17. Fischer V, Chen KS, Gage FH, Bjorklund A. Progressive decline in spatial learning and integrity of forebrain cholinergic neurones in rats during aging. Neurobiol Aging 1991;13:9-23.
18. Ghosal S, Lal J, Jaiswal AK, Bhattacharya SK. Effects of shilajit and its active constituents on learning and memory in rats. Phytother Res 1993;7:29-34.
19. Ghosal S, Lal J, Singh SK, Goel RK, Jaiswal AK, Bhattacharya SK. The need for formulation of shilajit by its isolated active constituents. Phytother Res 1991;5: 211-216.
20. Ghosal S, Mukhopadhyay B, Bhattacharya SK. Shilajit, a comparative study of the ancient and modern scientific findings. Indian J Indg Med 1995;17:1-10.
21. Ghosal S, Mukhopadhyay B, Bhattacharya SK 1997 Shilajit: a rasayana (immunomodulator) of Indian Traditional medicine. In Siva Sankar DV (ed) Molecular Basis of Asian Medicine, PJD Publications, New Jersey, In Press.
22. Ghosal S, Lal J, Srivastava RS, Bhattacharya SK, Upadhyay SN, Jaiswal AK, Chattopadhyay U. Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somnifera. Phytother Res 1989;3:201-206.
23. Ginn SR, Peterson GM. Studies related to the use of colchicine as a neurotoxin in septohippocampal cholinergic system. Brain Res 1992;590:144-152.
24. 3-dopa in various brain regions. J Neurochem 1966;13:655-669.
25. Growdon JH. Treatment for Alzheimer's disease? N Engl J Med 1992;327:1366-1368.
26. Haba K, Ogawa N, Kawata M, Mori A. A method for parallel determination of choline acetyltransferase and muscarinic cholinergic receptors: Application in aged rat brain. Neurochem Res 1988;13:951-958.
27. Halliwell B. Oxidants and the central nervous system: some fundamental questions. Acta Neurol Scand 1989;126:23-33.
28. Halliwell B. Drug antioxidant effects. A basis for drug selection? Drugs 1991;42:569-605.
29. Jaiswal AK, Bhattacharya SK. Effects of shilajit on memory, anxiety and brain monoamines in rats. Indian J Pharmacol 1992;24:12-17.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein estimation with Folin-phenol reagent. J Biol Chem. 1951;193:265-275.
31. Means LW, Franklin RD, Cliett CE. Failure of piracetam to facilitate acquisition of retention in younger and older rats. Exp Aging Res 1980;6:175-180.
32. Moos WH, Davis RE, Schwartz RD, Gamzu ER. Cognition activators. Med Res Rev 1988;8:351-391.
33. Mukherjee BP, Roy U. Neuropharmacological profile of a herbal medicine formulation (Trasina) with special reference to antistress activity. Indian Med J 1990;84:1-5.
34. Muller WE. Restoration of age-related receptor deficits in central nervous system, a common mechanism of nootropic action? Meth Find Exp Clin Pharmacol 1988;10:773-783.
35. Nakamura S, Ishihara T. Task dependent memory loss and recovery following unilateral nucleus basilis lesion: Behavioural and neurochemical correlation. Behav Brain Res 1990;39:113-122.
36. Ogawa N, Mizuno S, Nukina T, Tsukamoto S, Mori A. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS. Brain Res 1983;263:348-350.
37. Pedata F, Moroni F, Pepeu GC. Effects of nootropic agents on brain cholinergic mechanisms. Clin Neuropharmacol 1984;7(Suppl 1):772-773.
38. Pellegrino LJ, Pellegrino AS, Cushman AJ 1979 A stereotaxix atlas of rat brain. Plenum Press, New York.
39. Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian ginseng) and shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int 1997;30:181-190.
40. Seth PK, Agarwal AK, Bondy SC. Biochemical changes in the brain consequent to dietary exposure of developing and mature rats to chlordecone (kepone). Toxicol Appl Pharmacol 1981;59:262-267.
41. Sharma PV 1978 Dravyaguna Vijnan. Fourth edition Chaukhamba Sanskrit Sansthan, Varanasi.
42. Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN. Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 1983;40:503-509.
43. Smith G. Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res Rev 1988;13:103-118.
44. Speeg KV Jr 1974 A sensitive and specific fluorometric method for determination of acetylcholine. In Hanin I (ed) Choline and Acetylcholine: Handbook of Chemical Assay Methods. Raven Press, New York, p. 129.
45. Sunderland T, Molchan SE, Zubenko GS 1995 Biological markers in Alzheimer's disease. In Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, p. 1389.
46. Takahashi M, Sugaya K, Kubota K. Kangenkaryu prevents the decrease of cholinergic markers following nucleus basilis magnocellularis lesion. Jpn J Pharmacol 1992;60: 307-310.
47. Udupa KN, Singh RH 1993 Clinical and Experimental Studies on Rasayana Drugs and Panchkarma Therapy. Central Council for Research in Ayurveda and Siddha, New Delhi.